Home » Headlines » Currently Reading:

Morning Headlines 2/13/17

February 12, 2017 Headlines 1 Comment

Cerner (CERN) Q4 2016 Results – Earnings Call Transcript

In its Q4 earnings call, Cerner President Zane Burke reports bookings were up seven percent, compared to 28 percent growth in 2015, calling the results “solid, particularly when you consider the headwinds created by declines in tech resale.”

Work, Health, And Insurance: A Shifting Landscape For Employers And Workers Alike

A Health Affairs study examines the relationship between work, health, and health insurance given the changing demographic and employment conditions in the US.

Bias in the ER

Michael Lewis, author of “Moneyball” and “The Big Short,” argues in his new book that doctors are just as likely to ignore statistics, often treating a statistically unlikely diagnosis that fits the observable symptoms. He quotes a Canadian trauma center doctor who explains, “You need to be so careful when there is one simple diagnosis that instantly pops into your mind that beautifully explains everything all at once.”

Marathon Pharmaceuticals to Charge $89,000 for Muscular Dystrophy Drug After 70-Fold Increase

Marathon Pharmaceuticals intends to bring a drug used to treat muscular dystrophy to the US for $89,000 per year, while it is available in Europe for just $1,600 per year.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there is "1 comment" on this Article:







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...
  • Former Newspaper Guy: I applaud your attention to grammar and style. In high school, I worked for the local newspaper in the sports department...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links